Company intelligence / Profile preview

BREVENA Laboratories

St. Paul, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

BREVENA Laboratories is a commercial-stage skincare company that leverages proprietary Macro β-Glucan technology to develop advanced dermatological products. Originally derived from medical research into wound healing and burn care, the company's core technology is designed to stimulate the skin's natural renewal process and strengthen the moisture barrier. BREVENA offers a suite of products including intensive creams, balms, and daily lotions targeted at sensitive, aging, and post-procedure skin. The company focuses on providing clinical-grade hydration and repair solutions for both consumer and professional dermatological use.

Therapeutic areas: Dermatology
Modalities: PolysaccharideBiologic
Industry: Biotech

Beyond the preview

Go deeper on BREVENA Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BREVENA Laboratories.

Explore the full profile